Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of 1,6-Hexanediol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.35 |
| ▸ | MIF | P14174 | 1/20 | 0.32 |
| ▸ | GBA1 | P04062 | 4/20 | 0.31 |
| ▸ | PYGL | P06737 | 1/20 | 0.31 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1,6-Hexanediol SCHEMBL28159030 | 0.96 | LMNA (0.44) | HIF1AMAPTPDE4AKDRLMNA | |
| 1-Hexanol SCHEMBL26102045 | 0.86 | LMNA (0.68) | MAPTLMNAALDH1A1TSHRHSD17B10 | |
| 1-Hexanol SCHEMBL28925761 | 0.84 | LMNA (0.65) | MAPTLMNAALDH1A1TSHRHSD17B10 | |
| Cetostearyl Alcohol SCHEMBL10378874 | 0.82 | LMNA (0.72) | MAPTLMNAALDH1A1TSHRHSD17B10 | |
| Piperazine SCHEMBL9877421 | 0.81 | HIF1A (0.55) | HIF1AMAPTPDE4AKDRALDH1A1 | |
| 1,6-Hexanediol SCHEMBL20899393 | 0.76 | TSHR (0.53) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL5475929 | 0.76 | — | — | |
| SCHEMBL25302278 | 0.76 | TSHR (0.61) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| 1,4-Butanediol SCHEMBL21630075 | 0.76 | TSHR (0.61) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL21462773 | 0.76 | TSHR (0.61) | LMNAALDH1A1TSHRHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105324368-B | Compound suitable for the detection of vesica acetylcholine transporter | 浜松光子学株式会社 | 2017-09-12 | — | — | CN | disclosed |
| US-8835492-B2 | Temperature and pH sensitive block copolymer and polymeric hydrogels using the same | SUNGYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2014-09-16 | — | — | US | disclosed |
| US-20080293827-A1 | Temperature and Ph Sensitive Block Copolymer and Polymeric Hydrogels Using the Same | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR COROPORATE COLLABORATION (KR) | 2008-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293827-A1 | Temperature and Ph Sensitive Block Copolymer and Polymeric Hydrogels Using the Same | LRBA, DAO, PAM | HIF1A 1102/4885MAPT 1358/4885PDE4A 2203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.